
Notizie

29 ott 2021
3D SYSTEMS ACQUIRES VOLUMETRIC BIOTECHNOLOGIES TO ACCELERATE BIO-PRINTING OF HUMAN ORGANS
3D Systems has just announced the acquisition of Volumetric Biotechnologies, a Houston-based biotech company. From the outset Volumetric's mission has been to develop the ability to manufacture human organs using bioprinting methods. Its bioengineers and scientists have made tremendous progress in these efforts, focusing primarily on the human liver and the underlying technologies required to create these highly complex biological structures. With this acquisition, 3D Systems plans to establish a world-class research capability in Houston, Texas, a region committed to leadership in technologies related to life sciences.
A BIG ACQUISITION FOR A BETTER LIVE
The transaction is structured as a $45 million deal- closing payment, with up to $355 million available for additional opportunities linked to the achievement of significant steps in the demonstration of human applications over the next few years. These payments are all comprised of approximately half cash and half stock. If all milestones are accomplished, the total purchase price for the acquisition will be $400 million.
3D SYSTEMS: READY TO CREATE AN UNLIMITED SUPPLY OF LIFE-SAVING ORGANS
"The addition of Jordan Miller's Volumetric Biotechnologies and his exceptional team to our existing team will dramatically expand our capabilities and capacity for the development of bioprinted human organs. Dr. Miller, who will be appointed chief scientist for regenerative medicine at 3D Systems, will supplement the rapidly advancing efforts of the 3D Systems and united therapeutics team focused on the manufacture of human lungs, and expand these efforts to include additional human organs and other applications within the human body. Merging our groups, with their highly complementary skill sets, is expected to accelerate attainment of our primary mission, which is to create an unlimited supply of life-saving organs for the millions of people in need of a transplant around the world," said Jeffrey Graves, president and chief executive officer of 3D Systems.
VOLUMETRIC BIOTECHNOLOGIES: UNITED TO MANUFACTURE HUMAN ORGANS
"It has always been my dream to develop the capability to manufacture fully biocompatible human organs to save the lives of millions of people in need around the world. Our work on a vertically integrated platform for the 3D printing of organ scaffolds followed by cellularization to create fully compatible human organs, dovetails perfectly with the work being done by 3D Systems and United Therapeutics. Working together, we expect to accelerate these efforts, expanding them beyond lungs to other human organs. In addition, these capabilities are expected to enable numerous additional applications for printing vascularized human tissue to address needs created by trauma or disease," added Miller.
Numero visualizzazioni:355
Articoli che potrebbero interessarti

25 apr 2025
CALORIFERI IRSAP IN VENETO: ALIPLAST RECUPERA GLI SCARTI DI IMBALLAGGIO
In primo piano
VENDI ANCHE TU ONLINE
Con PlasticFinder l'inserzione è anonima, gratuita e vieni pagato in anticipo per i prodotti venduti.